Rapamycin and quasi-programmed aging: four years later
- PMID: 20436272
- DOI: 10.4161/cc.9.10.11872
Rapamycin and quasi-programmed aging: four years later
Abstract
In 2006, Cell Cycle featured the concept that aging is not caused by molecular damage (nor by free radicals) but instead is a purposeless quasi-program (program-like, but not a program) driven in part by TOR (Target of Rapamycin). Taken together with the analysis of clinical data, this pointed to Sirolimus (rapamycin) as a genuine anti-aging drug which will prolong life in humans and prevent age-related diseases by slowing down aging. Since that time many predictions of this concept have been confirmed. Rapamycin was shown to suppress aging in mammalian cells, prolong life span in mice and flies, improve immunity and stem cell function in old animals, thus confirming twelve predictions as discussed herein. One prediction remains to be confirmed: rapamycin will become the cornerstone of anti-aging therapy in our life time.
Similar articles
-
Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.Cell Cycle. 2006 Sep;5(18):2087-102. doi: 10.4161/cc.5.18.3288. Epub 2006 Sep 15. Cell Cycle. 2006. PMID: 17012837 Review.
-
Rapamycin extends life- and health span because it slows aging.Aging (Albany NY). 2013 Aug;5(8):592-8. doi: 10.18632/aging.100591. Aging (Albany NY). 2013. PMID: 23934728 Free PMC article.
-
How to save Medicare: the anti-aging remedy.Aging (Albany NY). 2012 Aug;4(8):547-52. doi: 10.18632/aging.100479. Aging (Albany NY). 2012. PMID: 22915707 Free PMC article.
-
TOR-driven aging: speeding car without brakes.Cell Cycle. 2009 Dec 15;8(24):4055-9. doi: 10.4161/cc.8.24.10310. Epub 2009 Dec 9. Cell Cycle. 2009. PMID: 19923900
-
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond.Cold Spring Harb Perspect Med. 2016 May 2;6(5):a025924. doi: 10.1101/cshperspect.a025924. Cold Spring Harb Perspect Med. 2016. PMID: 27048303 Free PMC article. Review.
Cited by
-
My battle with cancer. Part 1.Oncoscience. 2024 Jan 3;11:1-14. doi: 10.18632/oncoscience.593. eCollection 2024. Oncoscience. 2024. PMID: 38188499 Free PMC article. Review.
-
Ageing as a software design flaw.Genome Biol. 2023 Mar 28;24(1):51. doi: 10.1186/s13059-023-02888-y. Genome Biol. 2023. PMID: 36973715 Free PMC article. Review.
-
Rapamycin suppresses inflammation and increases the interaction between p65 and IκBα in rapamycin-induced fatty livers.PLoS One. 2023 Mar 3;18(3):e0281888. doi: 10.1371/journal.pone.0281888. eCollection 2023. PLoS One. 2023. PMID: 36867603 Free PMC article.
-
Cellular senescence: when growth stimulation meets cell cycle arrest.Aging (Albany NY). 2023 Feb 19;15(4):905-913. doi: 10.18632/aging.204543. Epub 2023 Feb 19. Aging (Albany NY). 2023. PMID: 36805938 Free PMC article.
-
Are menopause, aging and prostate cancer diseases?Aging (Albany NY). 2023 Jan 26;15(2):298-307. doi: 10.18632/aging.204499. Epub 2023 Jan 26. Aging (Albany NY). 2023. PMID: 36707068 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical